Glenmark Pharmaceuticals Receives FDA Clearance of IND for GSP 304
Glenmark Pharmaceuticals, a global pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) cleared the Company's Investigational New Drug (IND) application to…
Read More...
Read More...
